相关实验视频

Updated: Jun 29, 2025

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

在胃癌组织中评估HLA-DR和HLA-DQ表达

Narjes Jafari¹, Fatemeh Khajenabi², Nastaran Masumi¹

¹Immunogenetics Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Journal of cancer research and therapeutics

|March 30, 2024

概括

这项研究研究了胃癌 (GC) 中的人类白细胞抗原 (HLA) -DRA和HLA-DQA1mRNA水平. 虽然整体表达变化并不显著,但在瘤组织中观察到HLA-DRA和HLA-DQA1之间存在强烈的正相关性.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

胃癌 (GC) 的生物学和免疫反应在其进展中的作用仍然不完全理解.
人类白细胞抗原 (HLA) 类II分子在免疫调节中发挥作用.

研究的目的:

在胃癌患者中评估HLA-DRα (HLA-DRA) 和HLA-DQα1 (HLA-DQA1) 的mRNA水平.
探索HLA-II分子表达与胃癌发生之间的关联.

主要方法:

使用定量实时PCR (qRT-PCR) 来测量mRNA水平.
分析了20对匹配的胃癌和正常组织.

主要成果:

总的来说,HLA-DRA的mRNA水平呈现下降趋势 (中位数FC = 0.693),而HLA-DQA1在瘤组织中与正常组织相比呈现上升趋势 (中位数FC = 1.659),尽管在统计学上并不显著.
在瘤组织中的HLA-DRA和HLA-DQA1水平之间发现了显著的正相关性 (r = 0.7298,P = 0.0003).
对个体患者的分析显示,HLA-DRA和HLA-DQA1的上调和下调模式各不相同.

结论:

这些发现表明,HLA-II分子表达和胃癌发生之间存在复杂的相互作用.
需要进一步的研究来阐明免疫系统在GC中的作用.
这些见解可能有助于开发有效的基于免疫的胃癌治疗方法.

更多相关视频

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue

Published on: May 1, 2019

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

相关概念视频

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.